ADHD telehealth in California: what is real.

What the rules actually allow, what good telehealth ADHD care involves, and how to spot a pill mill.

Telehealth ADHD care exploded after 2020. The reality is more nuanced.

During the COVID-19 public-health emergency, federal rules around controlled-substance prescribing via telehealth were loosened. That created an opening for venture-backed adult-ADHD telehealth companies (Done, Cerebral, and others) to scale fast. Some of those services were careful. Some were not. Patients learned the hard way.

Since then, federal rules have been clarified and re-tightened in stages, and California has its own layer of rules on top. The result is a more careful telehealth landscape for adult ADHD than the 2020-2022 free-for-all suggested, but more permissive than the pre-2020 status quo.

This guide explains the parts that affect a California adult considering telehealth care today. It is not legal advice; rules change, and individual situations vary.

This guide is not legal advice. Rules change. Check sources or consult a professional for your specific situation.

Telehealth is regulated by the patient's location, not the doctor's.

For a California patient to receive care via telehealth, the doctor must be licensed in California. NorCal ADHD treats California residents only. Dr. D is licensed to practice in California. Patients in other states are not eligible, even if they used to live in California, even if they visit California briefly.

This is also why telehealth services advertised to "everywhere" with a long state list still actually have to maintain licensure in each individual state. The state-list page is the legal floor of where you can be a patient, not a marketing claim.

Many adult ADHD medications are controlled substances. The rules matter.

Stimulant medications commonly used for adult ADHD (amphetamines and methylphenidate compounds) are Schedule II controlled substances under federal law. That status carries specific rules about how they can be prescribed, dispensed, and refilled.

Telehealth-specific rules around controlled-substance prescribing exist on top of those federal rules and continue to evolve. The DEA has issued several rounds of temporary and proposed permanent rules since 2020. California has additional rules. Some require an in-person visit at certain stages of care; others do not.

What this means practically: a telehealth ADHD service that promises a prescription on the first call, with no follow-up, no labs, no coordination with primary care, and no mention of rules around refills is probably not following them carefully. A telehealth service that takes time to evaluate, follows up, and talks about pharmacy realistically is more likely to be operating inside the rules.

Less is suspicious. More is not always better.

A first appointment booked with enough room to listen, ask, and decide. At NorCal ADHD, the calendar reserves a 90-minute slot. Not a 7-minute prescription transaction.

Proactive follow-up from the doctor after care begins, not just on-demand responses to patient messages.

Care coordinated with the patient's primary care doctor, with pharmacies, and with insurance when authorizations are required.

Clarity about clinical boundaries, emergency limits, and referral paths when care needs another setting.

A few signals that a telehealth service is selling prescriptions, not providing care.

Instant prescription promises. Care decisions that should take a careful evaluation cannot be made in 15 minutes by a doctor who has not asked real questions.

Medication-on-demand language. Real ADHD care is not automatic in either direction; treatment depends on the patient.

Rotating providers. A different doctor every visit, or no consistent clinical relationship, is a structural signal that the service is not built around care.

No pharmacy support. If the service does not help with stock, substitutions, or authorizations, the patient is being asked to absorb the operational work the practice should be doing.

Operating at venture-backed scale. Adult ADHD care does not scale the way a SaaS product does. A practice that has to grow as fast as venture-capital expects probably has to cut corners somewhere.

No clear limits. A service that does not explain emergency boundaries, medication boundaries, and referral paths is hiding the limits that good care articulates plainly.

One doctor, one team, one standard of care.

NorCal ADHD is a private practice run by Dr. D. The practice is small enough that Dr. D sees every patient himself. The first appointment is booked as a 90-minute slot, though the actual visit length depends on what the appointment needs. Care between visits runs through Spruce with a guaranteed 24-hour reply. Dr. D messages first after care begins. Pharmacy work and authorizations are handled by the team, not the patient.

Care is private-pay and out-of-network. Insurance is required (because the broader care a patient might need lives outside NorCal ADHD), but NorCal ADHD does not bill insurance directly. Patients pay the practice; the practice provides superbills for possible reimbursement.

None of this is a marketing claim. It is how a careful adult ADHD telehealth practice has to operate to stay inside the rules, the clinical realities, and Dr. D's standard of care.

Not legal or medical advice; rules evolve and real clinical decisions depend on the doctor and patient. Not a directory; NorCal ADHD does not list other services. See what this practice is not.